
CVLT
USDCommvault Systems Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$138.850
Hoch
$139.600
Tief
$134.100
Volumen
0.54M
Unternehmensfundamentaldaten
Marktkapitalisierung
6.0B
Branche
Software - Application
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.74M
Börse
NMS
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
RBC Capital Maintains Sector Perform on CommVault Systems, Lowers Price Target to $167
RBC Capital analyst Dan Bergstrom maintains CommVault Systems with a Sector Perform and lowers the price target from $217 to $167.
Truist Securities Maintains Buy on CommVault Systems, Lowers Price Target to $210
Truist Securities analyst Junaid Siddiqui maintains CommVault Systems with a Buy and lowers the price target from $230 to $210.
Wells Fargo Maintains Overweight on CommVault Systems, Lowers Price Target to $190
Wells Fargo analyst Aaron Rakers maintains CommVault Systems with a Overweight and lowers the price target from $220 to $190.
Cantor Fitzgerald Maintains Neutral on CommVault Systems, Lowers Price Target to $144
Cantor Fitzgerald analyst Thomas Blakey maintains CommVault Systems with a Neutral and lowers the price target from $189 to $144.
Keybanc Maintains Overweight on CommVault Systems, Lowers Price Target to $185
Keybanc analyst Eric Heath maintains CommVault Systems with a Overweight and lowers the price target from $225 to $185.
Commvault Announces Second Quarter Fiscal 2026 Financial Results
Commvault (Nasdaq: CVLT) today announced its financial results for the fiscal second quarter ended September 30, 2025. "Commvault delivered a strong...
Baird Initiates Coverage On CommVault Systems with Outperform Rating, Announces Price Target of $215
Baird analyst Shrenik Kothari initiates coverage on CommVault Systems with a Outperform rating and announces Price Target of $215.
Ähnliche Aktien
RDCM
Radcom Ltd. Ordinary Shares
CELZ
Creative Medical Technology Holdings Inc.
DLY
DoubleLine Yield Opportunities Fund Common Shares of Beneficial Interest
APVO
Aptevo Therapeutics Inc.
IMUX
Immunic Inc.
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.